<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=896170837107954&amp;ev=PageView&amp;noscript=1">

Faster Recovery. Fewer Risks. Proven Outcomes.

clinical-results.jpg

“The UroLift clinical publication record is flawless.  Every patient treated under a clinical protocol appears in at least one peer-reviewed publication.  The outcomes from the numerous studies are consistent, demonstrating rapid relief within two weeks and sustained improvement in symptoms, quality of life and urinary flow.”

- Claus Roehrborn, MD

Clinical Results

Clinical results from over 25 peer-reviewed publications demonstrate that treatment with the UroLift® System offers rapid and significant improvements in symptoms, urinary flow and quality of life sustained through five years.   Compared to medications, the UroLift System has demonstrated a much more positive effect on quality of life for patients.1 The UroLift System treatment preserves sexual function and avoids complications typically associated with other BPH procedures.1,2 

 

UroLift System Treatment Delivers a Superior Patient Experience:

Rapid relief and recovery3,4
Lowest catheter rate of the leading BPH procedures3,5
No new, sustained erectile or ejaculatory dysfunction1,3,4
Proven durability through five years1

Redefining BPH Treatment

In the U.S. alone, there are 12.1 million men treated for BPH.Most patients living with BPH take prescription medications, but these medications can become a lifelong burden. In a recent men’s health survey, two out of three patients reported frustration with their current BPH prescription.7 These patients have been unwilling to consider a surgical procedure due to the perceived risks and invasive nature of the standard options. 

Now, urologists can offer men the UroLift System treatment—a BPH solution to improve their patient’s quality of life with minimal risk.

MarketWatch.jpg

What Patients Want: A Better Experience

Patients on BPH Medications Are Not Satisfied

  • 48% of patients on medications do not have a clinically significant improvement in symptoms (< 4 point IPSS improvement)8
  • 5ARI drugs take three to six months for symptom relief9,10
  • Side-effects include headaches, dizziness, asthenia, nasal congestion, loss of libido, ejaculatory dysfunction, erectile dysfunction2

Surgery is a Big Step for Patients      

  • Surgery with general anesthesia comes with operative risks: transfusion, significant hematuria2
  • Catheterization for days5
  • Four to six weeks irritative voiding symptoms and recovery2,11-13
  • Risk of permanent complications2
    • Urinary incontinence
    • Sexual dysfunction
    • Urethral stricture

Even Watchful Waiting Comes with Risks

  • Bladder outlet obstruction may result in irreversible bladder damage if left untreated14,15
  • 87% of men who elect watchful waiting experience a worsening of symptoms over a four year time period16
  • Men who delay TURP with watchful waiting have significantly worse outcomes than those who had TURP sooner17

Preservation of Sexual Function is Important to BPH Patients

In a global survey of over 13,000 men age 40-80 across 29 countries, nearly 50% rated sex as being very to extremely important.18 Erectile dysfunction contributes to anxiety, depression, loss of self-esteem and diminished quality of life.19  In choosing a BPH treatment, it is important to consider the impact that ejaculatory and erectile dysfunction have on patient satisfaction.

The UroLift System Treatment: The Only Approved BPH Procedure Shown to Preserve Sexual Function4

Sexual Preservation Table.jpg

Five Year Data Demonstrates That Outcomes Are Rapid, Durable and Reproducible

IPSS Improvement

Improvement in LUTS, as seen through average reduction in IPSS (International Prostate Symptom Score), has been consistent across the various studies, showing rapid relief within two weeks and sustained effect through five years.1 IPSS improvement at one year is better than seen with medications.2,4 

Quality of Life Improvement

Quality of life also improved significantly, with the IPSS QOL and BPH Impact Index maintaining 50% and 52% improvements, respectively at five years, p<0.0001.1

Flow Rate Improvement

In addition to improving LUTS, the UroLift System treatment has demonstrated significant average improvement in peak urinary flow rate (Qmax) of 3.5 mL/sec (44%) that was sustained to five years, p<0.0001.1

Low Retreatment Rate

The rate of surgical intervention for failure to cure with the UroLift System remains low for a BPH procedure, with approximately 13.6% over five years or about 2-3% per year.1 Over the first postoperative year, no additional surgical intervention was required for bladder neck contracture, bleeding, or stress incontinence in the pivotal study on UroLift System.4

5 Year Graph.jpg

View More Publications
Reimbursement Options